1,2,4-triazine derivatives, preparation and use thereof in human therapy
US7713971B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2006 |
| Grant date | May 11, 2010 |
| Priority date | — |
| Expiry date | Mar 2, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to 3,5-dioxo-(2H,4H)-1,2,4-triazine compounds of formula Iin which the variables are defined herein, as well as additive salts with pharmaceutically acceptable bases and the various enantiomers of compounds having asymmetrical carbons, as well as their mixtures in all proportions, including racemic mixtures in particular.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.